Table 7.
Treatment duration | ASAQ1 (N = 310) |
ASAQ2 (N = 315) |
AL (N = 311) |
Total (N = 936) |
Day 0 | ||||
N | 310 (100%) | 315 (100%) | 311 (100%) | 936 (100%) |
Density | 37781 ± 45652 | 41863 ± 49049 | 33958 ± 41474 | 37880 ± 45575 |
Day 1 | ||||
N | 198 (64.7%) | 194 (61.8%) | 206 (66.5%) | 598 (64.3%) |
Density | 3297 ± 8403 | 3137 ± 14753 | 3764 ± 14809 | 3406 ± 13002 |
Day 2 | ||||
N | 26 (8.6%) | 24 (7.7%) | 25 (8.1%) | 75 (8.1%) |
Density | 503 ± 787 | 914 ± 3230 | 1098 ± 2585 | 833 ± 2383 |
Day 3 | ||||
N | None | 2 (0.6%) | 4 (1.3%) | 6 (0.7%) |
Density | - | 154 ± 76 | 464 ± 296 | 361 ± 282 |
Data are presented as the number of patients with parasites (N) and as the mean parasite density ± SD for the patients with parasitaemia.